As filed with the Securities and Exchange Commission on March 18, 2025
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
KORRO BIO, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware |
|
47-2324450 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
60 First Street, 2nd floor, Suite 250
Cambridge, Massachusetts 02141
(Address of Principal Executive Offices, Zip Code)
Korro Bio, Inc. 2023 Stock Option and Incentive Plan
Korro Bio, Inc. 2023 Employee Stock Purchase Plan
(Full title of the plan)
Ram Aiyar
President and Chief Executive Officer
Korro Bio, Inc.
60 First Street, 2nd floor, Suite 250
Cambridge, Massachusetts 02141
(Name and address of agent for service)
(617) 468-1999
(Telephone number, including area code, of agent for service)
Copies to:
Jeffrey Cerio, Esq. General Counsel Korro Bio, Inc. 60 First Street, 2nd floor, Suite 250 Cambridge, Massachusetts 02141 (617) 468-1999 |
|
|
Kingsley L. Taft, Esq. Marianne C. Sarrazin, Esq. Goodwin Procter LLP 100 Northern Avenue Boston, MA 02210 (617) 570-1000 |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
Non-accelerated filer |
|
☒ |
|
Smaller reporting company |
|
☒ |
|
|
|
|
Emerging growth company |
|
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
Korro Bio, Inc. is filing this Registration Statement on Form S-8 for the purpose of registering an additional 468,863 shares of its common stock, par value $0.001 per share (the “Common Stock”), under the Korro Bio, Inc. 2023 Stock Option and Incentive Plan (the “2023 Plan”) and an additional 93,773 shares of Common Stock under the Korro Bio, Inc. 2023 Employee Stock Purchase Plan ( the “2023 ESPP”), pursuant to the provisions of each plan that provide for annual automatic increases in the number of shares of Common Stock reserved for issuance under each plan. In each case, the additional shares are of the same class as other securities for which a registration statement relating to the 2023 Plan and the 2023 ESPP has previously been filed and is effective. Accordingly, this registration statement incorporates by reference the contents of the registration statement on Form S-8 (File No. 333-275354), filed with the Securities and Exchange Commission (the “Commission”) on November 6, 2023, and the registration statement on Form S-8 (File No. 333-278245), filed with the Commission on March 26, 2024, relating to the 2023 Plan and the 2023 ESPP pursuant to General Instruction E, except with respect to Item 8. Exhibits thereof.
Part II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8. |
Exhibits. |
EXHIBIT INDEX
|
|
|
Exhibit |
|
Description |
|
|
|
4.1 |
|
|
|
|
|
4.2 |
|
|
|
|
|
4.3 |
|
|
|
|
4.4 |
|
|
|
|
|
4.5 |
|
|
|
|
|
5.1* |
|
|
|
|
|
23.1* |
|
|
|
|
|
23.2* |
|
|
|
|
|
24.1* |
|
|
|
|
|
99.1 |
|
|
|
|
|
99.2 |
|
|
|
|
|
107* |
|
* |
Filed herewith. |
SIGNATURES
Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cambridge, Commonwealth of Massachusetts, on this 18th day of March, 2025.
|
|
|
KORRO BIO, INC. |
||
|
|
|
By: |
|
/s/ Ram Aiyar |
|
|
Name: Ram Aiyar Title: President, Chief Executive Officer and Director |
POWER OF ATTORNEY AND SIGNATURES
KNOW ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears below hereby constitutes and appoints each of Ram Aiyar and Vineet Agarwal, as such person’s true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person in such person’s name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Commission granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that any said attorney-in-fact and agent, or any substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following person in the capacities and on the date indicated.
NAME |
|
TITLE |
|
DATE |
/s/ Ram Aiyar Ram Aiyar |
|
President, Chief Executive Officer and Director |
|
March 18, 2025 |
/s/ Oliver Dolan Oliver Dolan |
|
Senior Vice President, Finance Interim Principal Accounting Officer
|
|
March 18, 2025 |
/s/ Ali Behbahani Ali Behbahani |
|
Director
|
|
March 18, 2025 |
/s/ Nessan Birmingham Nessan Birmingham |
|
Director |
|
March 18, 2025 |
|
|
|
||
/s/ Jean-Francois Formela Jean-Francois Formela |
|
Director |
|
March 18, 2025 |
|
|
|
||
/s/ Katharine Knobil Katharine Knobil |
|
Director |
|
March 18, 2025 |
|
|
|
||
/s/ Rachel Meyers Rachel Meyers |
|
Director |
|
March 18, 2025 |
|
|
|
||
/s/ Timothy Pearson Timothy Pearson |
|
Director |
|
March 18, 2025 |